[HTML][HTML] Nanomedicine strategies to target coronavirus

MA Heinrich, B Martina, J Prakash - Nano Today, 2020 - Elsevier
With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …

[HTML][HTML] Artemisia annua: trials are needed for COVID‐19

FU Haq, M Roman, K Ahmad, SU Rahman… - Phytotherapy …, 2020 - ncbi.nlm.nih.gov
Beginning in December 2019, an increasing number of cases of novel coronavirus,
designated SARS-CoV-2, has caused worldwide outbreak of respiratory infection now …

Potential role of anti-interleukin (IL)-6 drugs in the treatment of COVID-19: rationale, clinical evidence and risks

S Crisafulli, V Isgro, L La Corte, F Atzeni, G Trifiro - BioDrugs, 2020 - Springer
The epidemic due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
infection has been spreading globally, raising increasing concerns. This public health …

[PDF][PDF] COVID-19 induced by SARS-CoV-2 causes Kawasaki-like disease in children: Role of pro-inflammatory and anti-inflammatory cytokines

R Ross, P Conti - J. Biol. Regul. Homeost. Agents, 2020 - researchgate.net
Acute severe respiratory syndrome coronavirus-2 (SARS-CoV-2) caused a global pandemic
coronavirus disease 2019 (COVID-19). In humans, SARS-CoV-2 infection leads to acute …

Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective

A Mardi, S Meidaninikjeh, S Nikfarjam… - Viral …, 2021 - liebertpub.com
The newfound coronavirus disease 2019 (COVID-19), initiated by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an international public health concern …

Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19

MT Rahman - Journal of herbal medicine, 2020 - Elsevier
An effective vaccine to prevent the SARS-CoV-2 causing COVID-19 is yet to be approved.
Further there is no drug that is specific to treat COVID-19. A number of antiviral drugs such …

Coronavirus (SARS-CoV-2) pandemic: Future challenges for dental practitioners

IR Bordea, E Xhajanka, S Candrea, S Bran, F Onișor… - Microorganisms, 2020 - mdpi.com
In the context of the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2)
pandemic, the medical system has been subjected to many changes. Face-to-face …

Review of oxygenation with nanobubbles: possible treatment for hypoxic COVID-19 patients

R Afshari, O Akhavan, MR Hamblin… - ACS Applied Nano …, 2021 - ACS Publications
The coronavirus disease (COVID-19) pandemic, which has spread around the world,
caused the death of many affected patients, partly because of the lack of oxygen arising from …

Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID‐19

M Ni, FB Tian, DD Xiang, B Yu - Journal of medical virology, 2020 - Wiley Online Library
To investigate the inflammatory factors and lymphocyte subsets which play an important role
in the course of severe coronavirus disease 2019 (COVID‐19). A total of 27 patients with …

The role of the SARS-CoV-2 S-protein glycosylation in the interaction of SARS-CoV-2/ACE2 and immunological responses

E Ramirez Hernandez, LF Hernandez-Zimbron… - Viral …, 2021 - liebertpub.com
The current pandemic is caused by the coronavirus disease 2019 (COVID-19), which is, in
turn, induced by a novel coronavirus (SARS-CoV-2) that triggers an acute respiratory …